Analyst hikes Healthways price target
The fourth-quarter earnings and 2013 outlook provided the other day by Healthways executives have convinced Dougherty & Co. analyst Brooks O'Neil to lift his price target for the Franklin company. O'Neil, who has reiterated his 'buy' rating, now sees Healthways going to $16 instead of $12. Healthways (Ticker: HWAY) is changing hands this morning around $10.55.
- ALEX B FRUIN INHERITANCE TRUST; CANDACE F STEFANSIC INHERITANCE TRUST; CANDANCE F STEFANSIC INHERITANCE TRUST; FRUIN, ALEX B TRUSTEE; FRUIN ALEX B INHERITANCE TRUST; STEFANSIC, CANDACE F TRUSTEE; STEFANSIC CANDACE F INHERITANCE TRUST; STEFANSIC CANDANCE F INHERITANCE TRUST
- ROSS, BRIDGETT D
- COOKE, ETHEN LANYARD TRUSTEE; COOKE, ETHEN LEWIS ESTATE
- JACOBS, JESSICA ALEXANDRA; JACOBS, ERIKA BESS
